Literature DB >> 31732615

Competing Risk Modeling: Time to Put it in Our Standard Analytical Toolbox.

Liang Li1, Wei Yang2, Brad C Astor3, Tom Greene4.   

Abstract

Keywords:  CKD; Competing risk; Statistical methodology

Mesh：

Year:  2019        PMID： 31732615      PMCID： PMC6900803          DOI： 10.1681/ASN.2019101011

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  7 in total

1.  Overview of model validation for survival regression model with competing risks using melanoma study data.

Authors:  Zhongheng Zhang; Giuliana Cortese; Christophe Combescure; Roger Marshall; Minjung Lee; Hyun Ja Lim; Bernhard Haller
Journal:  Ann Transl Med       Date:  2018-08

2.  Moderator's view: Predictive models: a prelude to precision nephrology.

Authors:  Carmine Zoccali
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

Review 3.  Assessing risk in chronic kidney disease: a methodological review.

Authors:  Morgan E Grams; Josef Coresh
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

4.  Influence of Mortality on Estimating the Risk of Kidney Failure in People with Stage 4 CKD.

Authors:  Pietro Ravani; Marta Fiocco; Ping Liu; Robert R Quinn; Brenda Hemmelgarn; Matthew James; Ngan Lam; Braden Manns; Matthew J Oliver; Giovanni F M Strippoli; Marcello Tonelli
Journal:  J Am Soc Nephrol       Date:  2019-09-20       Impact factor: 10.121

5.  Quantifying and estimating the predictive accuracy for censored time-to-event data with competing risks.

Authors:  Cai Wu; Liang Li
Journal:  Stat Med       Date:  2018-05-15       Impact factor: 2.373

6.  Semi-Competing Risks Data Analysis: Accounting for Death as a Competing Risk When the Outcome of Interest Is Nonterminal.

Authors:  Sebastien Haneuse; Kyu Ha Lee
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-04-12

7.  Competing risks and the clinical community: irrelevance or ignorance?

Authors:  Michael T Koller; Heike Raatz; Ewout W Steyerberg; Marcel Wolbers
Journal:  Stat Med       Date:  2011-09-23       Impact factor: 2.373
  7 in total
  6 in total

1.  Longitudinal Follow-Up and Outcomes for Chinese Patients with Stage 1-4 Chronic Kidney Disease.

Authors:  Jinwei Wang; Jicheng Lv; Kevin He; Fang Wang; Bixia Gao; Ming-Hui Zhao; Luxia Zhang
Journal:  Kidney Dis (Basel)       Date:  2021-10-27

2.  Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.

Authors:  Chava L Ramspek; Marie Evans; Christoph Wanner; Christiane Drechsler; Nicholas C Chesnaye; Maciej Szymczak; Magdalena Krajewska; Claudia Torino; Gaetana Porto; Samantha Hayward; Fergus Caskey; Friedo W Dekker; Kitty J Jager; Merel van Diepen
Journal:  J Am Soc Nephrol       Date:  2021-03-08       Impact factor: 10.121

3.  Lessons learnt when accounting for competing events in the external validation of time-to-event prognostic models.

Authors:  Chava L Ramspek; Lucy Teece; Kym I E Snell; Marie Evans; Richard D Riley; Maarten van Smeden; Nan van Geloven; Merel van Diepen
Journal:  Int J Epidemiol       Date:  2022-05-09       Impact factor: 9.685

4.  The Kidney Failure Risk Equation for Prediction of Allograft Loss in Kidney Transplant Recipients.

Authors:  Chi D Chu; Elaine Ku; Mohammad Kazem Fallahzadeh; Charles E McCulloch; Delphine S Tuot
Journal:  Kidney Med       Date:  2020-10-28

5.  Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia.

Authors:  Murilo Guedes; Daniel G Muenz; Jarcy Zee; Brian Bieber; Benedicte Stengel; Ziad A Massy; Nicolas Mansencal; Michelle M Y Wong; David M Charytan; Helmut Reichel; Sandra Waechter; Ronald L Pisoni; Bruce M Robinson; Roberto Pecoits-Filho
Journal:  J Am Soc Nephrol       Date:  2021-07-08       Impact factor: 14.978

Review 6.  Introduction to clinical research based on modern epidemiology.

Authors:  Junichi Hoshino
Journal:  Clin Exp Nephrol       Date:  2020-03-24       Impact factor: 2.801
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.